ethyl 1-(2-(1H-indol-3-yl)ethyl)-5-(2-hydroxybenzoyl)-2-oxo-1,2-dihydropyridine-3-carboxylate | 1432594-79-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: ethyl 1-(2-(1H-indol-3-yl)ethyl)-5-(2-hydroxybenzoyl)-2-oxo-1,2-dihydropyridine-3-carboxylate
• 英文别名: ethyl 5-(2-hydroxybenzoyl)-1-[2-(1H-indol-3-yl)ethyl]-2-oxopyridine-3-carboxylate
• CAS: 1432594-79-0
• 化学式: C₂₅H₂₂N₂O₅
• 分子量: 430.46
• InChiKey: VDKGBYNNGCHCST-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  32
• 可旋转键数：
  8
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.16
• 拓扑面积：
  99.7
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  2'-羟基苯乙酮 在 乙酸酐 、 potassium carbonate 、 cesium fluoride 、 三氯氧磷 作用下， 以 二氯甲烷 为溶剂， 反应 1.0h， 生成 ethyl 1-(2-(1H-indol-3-yl)ethyl)-5-(2-hydroxybenzoyl)-2-oxo-1,2-dihydropyridine-3-carboxylate
  参考文献：
  名称：

  [EN] COMPOUNDS AND METHODS FOR INHIBITING EMT PATHWAYS TO TREAT CANCER, ORGAN FIBROSIS AND METABOLIC DISORDERS
  [FR] COMPOSÉS ET PROCÉDÉS POUR INHIBER LES VOIES EMT POUR TRAITER LE CANCER, LA FIBROSE D'ORGANE ET LES TROUBLES MÉTABOLIQUES

  摘要：

  化合物，或其药用可接受的盐或异构体，其化学式为I：其中R为氢、烷基、取代烷基、烯基或取代烯基；R1为氢、烷氧基或取代烷氧基；R2为氢、烷基或取代烷基；R3为氢、烷基或取代烷基。

  公开号：

  WO2018156459A1

文献信息

• Eco-friendly synthesis of diverse and valuable 2-pyridones by catalyst- and solvent-free thermal multicomponent domino reaction
  作者：Tej Narayan Poudel、Yong Rok Lee、Sung Hong Kim

  DOI：10.1039/c5gc01526j

  日期：——

  An eco-friendly protocol for diverse and functionalized 2-pyridone derivatives via a multicomponent reaction under catalyst- and solvent-free conditions has been developed.

  已经开发了一种在无催化剂和无溶剂条件下通过多组分反应进行多样且功能化的2-吡啶酮衍生物的环保方案。
• Compounds and methods for inhibiting EMT pathways to treat cancer, organ fibrosis and metabolic disorders
  申请人：University of Pittsburgh—Of the Commonwealth System of Higher Education

  公开号：US11078159B2

  公开（公告）日：2021-08-03

  A compound, or a pharmaceutically acceptable salt or isomer thereof, of Formula I: wherein R is hydrogen, alkyl, substituted alkyl, alkenyl, or substituted alkenyl; R1 is hydrogen, alkoxy, or substituted alkoxy; R2 is hydrogen, alkyl, or substituted alkyl; and R3 is hydrogen, alkyl, or substituted alkyl.

  式 I 的化合物或其药学上可接受的盐或异构体： 其中 R 是氢、烷基、取代烷基、烯基或取代烯基； R1 是氢、烷氧基或取代的烷氧基 R2 是氢、烷基或取代烷基；和 R3 是氢、烷基或取代的烷基。
• A versatile domino process for the synthesis of substituted 3-aminomethylene-chromanones and 2-pyridones catalyzed by CsF
  作者：Catalin Pintiala、Ata Martin Lawson、Sébastien Comesse、Adam Daïch

  DOI：10.1016/j.tetlet.2013.03.096

  日期：2013.5

  The addition of various primary amines onto 3-alpha,beta-unsaturated diester chromone derivative was studied under mild conditions. Basically, this reaction provided 2-pyridone-based compounds through an interesting domino 'Addition/Ring Opening/Ring Closure' process (ARORC). In this study, aniline and tryptamine series exhibited different reactivity profiles leading unexpectedly to 3-aminomethylene chromanones with or without the 2-pyridone derivatives. This constitutes the first description and study of 3-aminomethylene chromanone formation that is supposed to follow a domino process combining 'Addition/Ring Opening/Ring Closure by Oxa-Michael addition' (ARORCOM). (C) 2013 Elsevier Ltd. All rights reserved.
• KR101795283
  申请人：——

  公开号：——

  公开（公告）日：——
• COMPOUNDS AND METHODS FOR INHIBITING EMT PATHWAYS TO TREAT CANCER, ORGAN FIBROSIS AND METABOLIC DISORDERS
  申请人：University of Pittsburgh - Of the Commonwealth System of Higher Education

  公开号：US20220017466A1

  公开（公告）日：2022-01-20

  A compound, or a pharmaceutically acceptable salt or isomer thereof, of Formula I: wherein R is hydrogen, alkyl, substituted alkyl, alkenyl, or substituted alkenyl; R 1 is hydrogen, alkoxy, or substituted alkoxy; R 2 is hydrogen, alkyl, or substituted alkyl; and R 3 is hydrogen, alkyl, or substituted alkyl.